8-K: Current report filing
Published on May 28, 2010
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): May 26, 2010
ACCESS
PHARMACEUTICALS, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
0-9314
|
83-0221517
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
2600
Stemmons Freeway, Suite 176
Dallas,
TX 75207
(Address
of principal executive offices) (Zip Code)
(214)
905-5100
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction
A.2. below):
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
Item
5.07. Submission of Matters to a Vote of Security
Holders.
|
The annual meeting of stockholders of
Access Pharmaceutical, Inc. (the “Company”) was held on May 26,
2010. The following matters were acted upon:
1. ELECTION
OF DIRECTORS
Mark J.
Ahn, Ph.D and Mark J. Alvino were both elected to serve as directors of the
Company until their successors are duly elected and qualified. The
results of the election of directors are as follows:
|
Nominee
|
Votes
For
|
Votes
Withheld
|
|
Mark
J. Ahn, Ph.D
|
14,057,346
|
581,269
|
|
Mark
J. Alvino
|
13,864,613
|
774,002
|
2. AMENDMENT
OF THE COMPANY’S 2005 EQUITY INCENTIVE PLAN
A proposal to amend the Company’s 2005
Equity Incentive Plan was approved by the following votes:
|
Votes
For
|
Votes
Against
|
Abstain
|
Broker
Non-Votes
|
|
13,520,119
|
830,248
|
288,247
|
5,612,878
|
3. RATIFICATION
OF APPOINTMENT OF WHITLEY PENN LLP AS THE INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM OF THE COMPANY.
Ratification of the appointment of
Whitley Penn LLP as the independent registered public accounting firm of the
Company was approved by the following votes:
|
Votes
For
|
Votes
Against
|
Abstain
|
Broker
Non-Votes
|
|
19,823,921
|
130,454
|
25,366
|
0
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Access Pharmaceuticals,
Inc.
(Registrant)
By: /s/ Stephen
B. Thompson
Stephen
B. Thompson
Vice
President and
Chief
Financial Officer
Dated May
29, 2010